跳至主要内容
临床试验/NCT01939678
NCT01939678终止不适用

Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease

Region Örebro County1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
1
主要终点
Mutations in sodium-phosphate cotransporters in patients with calcific aortic valve disease

研究概览

简要总结

The purpose of this study is to investigate whether mutations in genes coding for Na/Pi-cotransporters are associated with aortic valve calcification. A patient population with premature aortic valve calcification treated with aortic valve replacement will be screened for mutations in these specific genes. Furthermore, aortic valve tissue received from the operations, will be examined for the presence of Na/Pi-cotransporters, and for molecular characterization of the transporters.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
— 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with aortic valve calcification that will be treated with an aortic valve replacement.
  • Age ≤ 65 years.
  • Signed and dated informed consent.

排除标准

  • Inability to provide informed consent
  • Earlier radiation therapy of the thorax
  • Severe renal disease (patients in treatment with dialysis)

结局指标

主要结局

Mutations in sodium-phosphate cotransporters in patients with calcific aortic valve disease

时间窗: At the time of aortic valve replacement

Mutations in genes coding for Na/Pi-cotransporters

次要结局

未报告次要终点

研究者

发起方
Region Örebro County
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ole Frobert, MD, PhD

MD, PhD

Region Örebro County

研究点 (1)

Loading locations...

相似试验

Characterization and Role of Mutations in... | 临床试验